Peter Thompson, Terremoto Biosciences interim CEO
Former Principia team looks to shake up covalent small molecules again, this time at 'earthquake' scale
Terremoto Biosciences goes back a long ways, in a sense, to about a dozen years ago when Principia Biopharma was founded by UCSF professor Jack …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
